Principais Benefcios
Editorial assistance, redrawing figures, and formatting was provided by Carolyn Bowler, PhD, CMPP, of Apollo, OPEN Health Communications, and funded by Novo Nordisk A/S, in accordance with Good Publication Practice guidelines
This hormone plays a role in regulating appetite and food intake, making semaglutide a valuable tool for weight management
Eli Lilly is evaluating its lead asset, tirzepatide , in phase III obesity drug clinical trials for the reduction of morbidity and mortality in obesity
Long-term injection site management For people on tirzepatide for months or years, long-term injection site health becomes an important consideration
Retrieved from US Food and Drug Administration (FDA-a)